Mitochondria-specific drug release and reactive oxygen species burst induced by polyprodrug nanoreactors can enhance chemotherapy.
Zhang W, Hu X, Shen Q, Xing D. · 2019
Read Mitochondria-specific drug release and reactive oxygen species burst induced by polyprodrug nanoreactors can enhance chemotherapy. by Zhang W, Hu X, Shen Q, Xing D. (2019) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc6461692.txt.
Description
Zhang and co-authors build dual-targeting polyprodrug nanoreactors that amplify reactive oxygen species inside cancer cell mitochondria until the cell dies. Cancer cells already run about ten times the oxidant load of normal cells, and roughly 90 percent of it originates in mitochondria. The particles carry chains of the drug camptothecin and home to both tumor cells and their mitochondria.
Mitochondrial oxidants free the first camptothecin, which jams respiration and raises oxidant output further, releasing more drug in a self-feeding loop. The sustained burst overcomes the short life and tiny range of reactive species, the usual weakness of such therapies, and needs no external light. Treated cells showed wrecked mitochondria and apoptosis.
Catalog record
| CREATOR | Zhang W, Hu X, Shen Q, Xing D. |
|---|---|
| YEAR | 2019 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 68 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |